SLC7A11 and cancer: xCT inhibitors, such as sulfasalazine [232,233,234] and erastin [235,236,237,238,239], can reduce GSH and increase ROS in cancer cells, propagating iron-dependent lipid peroxidation that leads to tumor ferroptosis.